Evidence map›Paper›PMID 38212848›Full record

ArticleActa neuropathologica communications2024

Enhancing mitosis quantification and detection in meningiomas with computational digital pathology.

Hongyan Gu, Chunxu Yang, Issa Al-Kharouf, Shino Magaki, Nelli Lakis, Christopher Kazu Williams, Sallam Mohammad Alrosan, Ellie Kate Onstott, Wenzhong Yan, Negar Khanlou and 6 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Deep Learning-Based Tumor Cell Classification in Lung Adenocarcinoma With a Case-by-Case Human-in-the-Loop Approach.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026
    Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Hongyan GuElectrical and Computer Engineering, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
Chunxu YangElectrical and Computer Engineering, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
Issa Al-KharoufPathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Shino MagakiPathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, 90095, USA.
Nelli LakisPathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Christopher Kazu WilliamsPathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, 90095, USA.
Sallam Mohammad AlrosanPathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Ellie Kate OnstottPathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Wenzhong YanElectrical and Computer Engineering, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
Negar KhanlouPathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, 90095, USA.
Inma CobosDepartment of Pathology, Stanford Medical School, Stanford, CA, 94305, USA.
Xinhai Robert ZhangMcGovern Medical School, UT Health at Houston, Houston, TX, 77030, USA.
Neda Zarrin-KhamehBaylor College of Medicine, Houston, TX, 77030, USA.
Harry V VintersPathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, 90095, USA.
Xiang Anthony ChenElectrical and Computer Engineering, University of California, Los Angeles, Los Angeles, CA, 90095, USA. xac@ucla.edu.
Mohammad HaeriPathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS, 66160, USA. mhaeri@kumc.edu.ORCID 0000-0001-6055-9779
University of California, Los Angeles · USUniversity of Kansas Medical Center · USBaylor College of Medicine · USStanford Medicine · USThe University of Texas Health Science Center at Houston · US

Funding

Division of Information and Intelligent Systems IIS-1850183University of Kansas Medical Center Start-up fund
6 · The paper itself

Abstract

Mitosis is a critical criterion for meningioma grading. However, pathologists' assessment of mitoses is subject to significant inter-observer variation due to challenges in locating mitosis hotspots and accurately detecting mitotic figures. To address this issue, we leverage digital pathology and propose a computational strategy to enhance pathologists' mitosis assessment. The strategy has two components: (1) A depth-first search algorithm that quantifies the mathematically maximum mitotic count in 10 consecutive high-power fields, which can enhance the preciseness, especially in cases with borderline mitotic count. (2) Implementing a collaborative sphere to group a set of pathologists to detect mitoses under each high-power field, which can mitigate subjective random errors in mitosis detection originating from individual detection errors. By depth-first search algorithm (1) , we analyzed 19 meningioma slides and discovered that the proposed algorithm upgraded two borderline cases verified at consensus conferences. This improvement is attributed to the algorithm's ability to quantify the mitotic count more comprehensively compared to other conventional methods of counting mitoses. In implementing a collaborative sphere (2) , we evaluated the correctness of mitosis detection from grouped pathologists and/or pathology residents, where each member of the group annotated a set of 48 high-power field images for mitotic figures independently. We report that groups with sizes of three can achieve an average precision of 0.897 and sensitivity of 0.699 in mitosis detection, which is higher than an average pathologist in this study (precision: 0.750, sensitivity: 0.667). The proposed computational strategy can be integrated with artificial intelligence workflow, which envisions the future of achieving a rapid and robust mitosis assessment by interactive assisting algorithms that can ultimately benefit patient management.

Indexed as

Meningeal NeoplasmsMeningiomaArtificial IntelligenceHumansMitosisMitotic IndexDepth-first searchDigital pathologyMeningiomaMitosisPathologist group decision

Identifiers

PMID38212848
PMCPMC10782692
OpenAlexW4390751684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.